Revlimid

Revlimid (lenalidomide) is a medication primarily used to treat certain blood cancers, such as multiple myeloma and some myelodysplastic syndromes. It works by modifying the immune system, reducing abnormal cell growth, and preventing cancer cells from developing their blood supply. Revlimid is usually taken as a daily pill and is part of a broader treatment plan. Because it affects the immune system and blood cell production, it requires careful monitoring by healthcare providers to manage potential side effects and ensure safe use.